Ironwood Pharmaceuticals Inc

IRWD

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001446847

SEC filings (opens in a new tab)

In the last 90 days, Ironwood Pharmaceuticals Inc insiders filed 0 open-market purchases and 1 sale; 212 institutions reported holding it in 13F filings for Q2 2026, worth $675.8M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Ironwood Pharmaceuticals Inc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023 All holders in Q4 2022

13F holders of IRWD: Q4 2022 compared with Q1 2023
Measure	Q4 2022	Of which not filed for Q1 2023	Q1 2023	Change
Holders	250	2	255	+7
Shares	167.8M	350.7K	164.6M	−2.86M (−1.7%)
Value	$2.08B	$4.27M	$1.74B	−$331.6M (−16.0%)

2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Ironwood Pharmaceuticals Inc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to IRWD in Q1 2023
Institution	Shares	Value	% of portfolio
Balyasny Asset Management LLC	950,736	$10.0M	0.03%
Brandywine Global Investment Management, LLC	254,051	$2.67M	0.02%
Twinbeech Capital LP	199,921	$2.10M	0.04%
Exchange Traded Concepts, LLC	164,126	$1.73M	0.05%
Jefferies Financial Group Inc.	163,400	$1.72M	0.04%
Squarepoint Ops LLC	152,859	$1.61M	0.01%
Massachusetts Financial Services Co	91,973	$967.6K	0.00%
Skandinaviska Enskilda Banken AB (publ)	62,600	$659.0K	0.00%
Dynamic Technology Lab Private Ltd	52,985	$557.0K	0.05%
Quantbot Technologies LP	44,300	$466.0K	0.03%
Point72 Middle East FZE	36,850	$387.7K	0.02%
HighTower Advisors, LLC	32,689	$352.0K	0.00%
Y-Intercept (Hong Kong) Ltd	28,816	$303.1K	0.04%
Prairiewood Capital, LLC	28,233	$297.0K	0.20%
Robeco Institutional Asset Management B.V.	27,336	$287.6K	0.00%
AXA S.A.	21,900	$230.4K	0.00%
Fox Run Management, L.L.C.	19,668	$206.9K	0.07%
Teza Capital Management LLC	19,032	$200.2K	0.04%
Kula Investments, LLC	14,003	$147.3K	0.04%
Virtu Financial LLC	11,722	$123.0K	0.01%
Point72 Asset Management, L.P.	10,193	$107.2K	0.00%
Goodman Advisory Group, LLC	3,500	$36.8K	0.02%
Huntington National Bank	409	$4.30K	0.00%
Bessemer Group Inc	373	$4.00K	0.00%
Belpointe Asset Management LLC	105	$1.10K	0.00%
Baldrige Asset Management LLC	64	$1.00K	0.00%
Denali Advisors LLC	68	$715	0.00%

Sold out (20)

Institutions that held Ironwood Pharmaceuticals Inc at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of IRWD in Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Ally Bridge Group (NY) LLC	326,428	$4.04M
Phocas Financial Corp.	253,694	$3.14M
Westfield Capital Management Co LP	253,491	$3.14M
Globeflex Capital L P	121,452	$1.50M
New York Life Investment Management LLC	45,091	$558.7K
Seven Eight Capital, LP	29,843	$369.8K
Natixis Advisors, L.P.	27,475	$340.0K
Schonfeld Strategic Advisors LLC	24,700	$306.0K
Acrisure Capital Management, LLC	23,406	$290.0K
Watershed Asset Management, L.L.C.	23,366	$289.5K
NinePointTwo Capital	16,024	$198.0K
Sumitomo Mitsui Trust Holdings, Inc.	10,868	$134.7K
IFP Advisors, Inc	2,013	$38.0K
Anfield Capital Management, LLC	2,433	$30.1K
One Wealth Advisors, LLC	1,104	$13.7K
Corrado Advisors, LLC	200	$2.48K
Coastal Capital Group, Inc.	100	$1.04K
Rockefeller Capital Management L.P.	99	$1.00K
Ellevest, Inc.	40	$496
Sutton Wealth Advisors Inc.	9	$112

Not filed for Q1 2023 yet (2)

Institutions that held Ironwood Pharmaceuticals Inc at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IRWD in Q4 2022 that haven't filed for Q1 2023
Institution	Shares, Q4 2022	Value, Q4 2022
Monarch Partners Asset Management LLC	276,579	$3.43M
Comerica Bank	74,140	$846.0K